115 related articles for article (PubMed ID: 1445622)
1. 12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells.
Bernstein LR; Bravo R; Colburn NH
Mol Carcinog; 1992; 6(3):221-9. PubMed ID: 1445622
[TBL] [Abstract][Full Text] [Related]
2. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
3. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
[TBL] [Abstract][Full Text] [Related]
5. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
6. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation.
Ben-Ari ET; Bernstein LR; Colburn NH
Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542
[TBL] [Abstract][Full Text] [Related]
7. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
[TBL] [Abstract][Full Text] [Related]
8. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
9. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
10. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis.
Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH
Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
13. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.
Yoshioka K; Deng T; Cavigelli M; Karin M
Proc Natl Acad Sci U S A; 1995 May; 92(11):4972-6. PubMed ID: 7761434
[TBL] [Abstract][Full Text] [Related]
14. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
Wu WS; Lin JK; Wu FY
Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
[TBL] [Abstract][Full Text] [Related]
16. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
17. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
20. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
Liu G; Bode A; Ma WY; Sang S; Ho CT; Dong Z
Cancer Res; 2001 Aug; 61(15):5749-56. PubMed ID: 11479211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
